Outcome Company Profile

08:41 EDT 19th March 2018 | BioPortfolio

Outcome is the leading provider of strategies and solutions designed to meet the unique needs of the post-approval market. The Company focuses on program strategy and the practical deployment of registries, Phase IV studies, and risk management programs, including the application of state-of-the-art technology to better achieve the unique goals and requirements of the post-approval phase.Outcome's market-leading technology is distinguished by its scalability, performance and reliability. Additionally, the technology requirements of post-marketing programs are different than those of pre-approval trials. Ease of use, faster response times, better reporting and more value added features are critical for success.
Backed by expertise and experience in over 30 therapeutic areas, Outcome has designed, developed and managed an industry leading number of post-approval studies including more than 60 registries. These include many of the largest and most well-recognized programs for disease outcomes and safety/risk management. An Outcome registry has also received a 2004 Innovation Award from the Department of Health and Human Services. With more than 1 million patients enrolled in studies powered by Outcome and over 3,000 sites logging on to the Outcome system daily, the Company has by far the most widely used system in the industry. Outcome is headquartered in Cambridge, Mass.


201 Broadway
United States of America


Phone: (617) 621-1600
Fax: (617) 621-1620

News Articles [10 Associated News Articles listed on BioPortfolio]

Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore

MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) announced today that the U.S. International Trade Commission (the “ITC”) has termin...

Outcome from DSMB Safety Review and Extension of TACTI-mel Phase I Clinical Trial

SYDNEY, Australia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) (“Immutep” or the “Company”), announced today that the Database Safety Monitoring Board (“DS...

Empagliflozin Lowers CKD Incidence in T2D Patients

(MedPage Today) -- Post-hoc analysis of the EMPA-REG OUTCOME trial

Momenta Pharmaceuticals Announces Positive Outcome for Contracted Glatopa® (glatiramer acetate injection) Fill/Finish Manufacturer

-- McPherson, Kansas facility compliance status amended to Voluntary Action Indicated (VAI)-- -- VAI status provides the potential for the near-term FDA approval of Sandoz’s Glatopa 40 mg ANDA--...

Critical Outcome Technologies Annual and Special Meeting of Shareholders Rescheduled

LONDON, ONTARIO and BOSTON, MASSACHUSETTS -- (Marketwired) -- 12/06/17 -- Critical Outcome Technologies Inc. (TSX VENTURE: COT)(OTCQB: COTQF) ("COTI" or the "Company"), a clinical stage biopharmaceu...

FDA Nod For AGN, ZYME Strikes A Deal With Janssen Biotech, TCON Abuzz

Today's Daily Dose brings you news about expanded FDA approval for Allergan's schizophrenia drug; post-hoc analysis of Lilly's EMPA-REG OUTCOME trial; Court ruling against MediWound; extension of FDA'...

New Swedish study results at SABCS show DiviTum® blood test reduces waiting times for evaluating breast cancer treatment

Uppsala, Sweden, November 14, 2017. Results from a study of 142 women with newly diagnosed metastatic breast cancer will be presented by researchers from Lund University at the world’s biggest...

Empagliflozin shows CV benefit in patients with PAD

ANAHEIM, Calif. — Among patients with peripheral artery disease at baseline enrolled in the EMPA-REG OUTCOME trial, treatment with empagliflozin reduced the risk for mortality, CV events, HF hospita...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Cedax [Pernix Therapeutics, LLC]

CEDAX (ceftibuten capsules) and (ceftibuten for oral suspension)

PubMed Articles [19 Associated PubMed Articles listed on BioPortfolio]

Cardiorenal protection with SGLT2 inhibitors (gliflozins) : from EMPA-REG OUTCOME to CANVAS.

The cardiovascular (CV) and renal protection reported with empagliflozin in EMPA-REG OUTCOME is now confirmed with canagliflozin in CANVAS in patients with type 2 diabetes and high cardiovascular risk...

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial.

Empagliflozin reduced the risk of cardiovascular (CV) death and heart failure (HF) hospitalizations in patients with type 2 diabetes (T2D) and established CV disease (CVD) in the EMPA-REG OUTCOME® tr...


To evaluate the efficacy and optimum timing for resurgery in case of persistent macular hole (MH).


To evaluate the clinical features and surgical outcomes of rhegmatogenous retinal detachment in pediatric patients and to identify the independent effect of each etiology on the outcome.


Gastrointestinal carcinoid tumours, despite their low malignant potential, frequently metastasize to the liver. While liver resection improves survival and provides symptomatic relief, multifocal bilo...

Clinical Trials [22 Associated Clinical Trials listed on BioPortfolio]

Comparing Program Options for Latinos With Diabetes

BACKGROUND AND SIGNIFICANCE: Diabetes is a national health problem, yet Latinos from low-income households are at greater risk. Although guidelines recommend that patients learn self-mana...

Comparative Effectiveness of Empagliflozin in the US

Empagliflozin, a sodium glucose co-transporter 2 (SGLT-2) inhibitor, was launched as a treatment for type 2 diabetes mellitus (T2DM) in the U.S. in August 2014. In contrast with several pr...

Nefopam/Fentanyl Postoperative Intravenous Patient-Controlled-Analgesia

BACKGROUND : There has been increasing interest on the use of nefopam in i.v. patient-controlled analgesia (PCA). OBJECTIVE : The aim of this study was to evaluate the opioid-sparing effe...

Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome

Myo-Inositol is classified as a member of the vitamin B complex. It is a constituent of living cells and is widespread in many food. It is involved in a number of biological processes, inc...

Can Safety Planning Improve Perinatal Outcomes Among Pregnant Women Exposed to Intimate Partner Violence?

OBJECTIVE: To investigate if, among women exposed to physical violence during pregnancy, does a targeted intervention consisting of safety planning and referral to community advocacy servi...

Companies [8 Associated Companies listed on BioPortfolio]

Outcomes Pharmaceutical Health Care

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides serv...


Outcome is the leading provider of strategies and solutions designed to meet the unique needs of the post-approval market. The Company focuses on program strategy and the practical deployment of regis...

Outcome Sciences, Inc.

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides serv...

NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB ( is a Swedish drug development company whose primary mission is to develop drugs for the treatment of acute brain injury, reperfusion injury in myocard...

N.C. Stroke Association

NCSA is a 501 (c) 3 organization founded in 1998 by a group of physicians and lay people who saw the need to address the state’s increasing prevalence of stroke and it...

More Information about "Outcome" on BioPortfolio

We have published hundreds of Outcome news stories on BioPortfolio along with dozens of Outcome Clinical Trials and PubMed Articles about Outcome for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Outcome Companies in our database. You can also find out about relevant Outcome Drugs and Medications on this site too.

Quick Search


Relevant Topic

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record